Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$3.76 - $6.29 $115,432 - $193,103
30,700 New
30,700 $172,000
Q4 2021

Feb 14, 2022

SELL
$8.12 - $10.37 $144,820 - $184,948
-17,835 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$7.48 - $11.38 $25,619 - $38,976
3,425 Added 23.77%
17,835 $174,000
Q2 2021

Aug 16, 2021

BUY
$7.16 - $9.56 $103,175 - $137,759
14,410 New
14,410 $118,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $24.7M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.